DDW ARTICLE DATABASE

THIS MONTH'S LIFE SCIENCE MOVIES
Superheroes
SpectraMax i3 Multi-Mode Detection System
See how you can do more with your microplate reader than you ever imagined.
Watch Video
Waters
Bioanalysis of Oxytocin
Ultrasensitive Quantification Assay for Oxytocin in Human Plasma Using an LC/MS Microfluidics Platform
Watch Video
LATEST ISSUE:

Valuation in portfolio management

By Dr Michel Azoulay
Throughout the course of my career, I have been involved in a wide range of portfolio decisions and continue to be involved in them today. Over the years, it has been observed that despite cultural differences, pharma teams face similar problems.
 

The use of syngeneic models for the discovery of targets for combination therapy and predictive biomarkers of immunotherapy efficacy

By Dr Jean- Pierre Wery
Optimal treatment for any disease is one that can cure or prevent spreading with minimal impact on the patient’s quality of life.
 

CAR-T : Looking beyond the hype

By Christoph Oldenburg, Dr Markus Thunecke and Dr John Herrmann
While CAR-T have already demonstrated convincing efficacy in a specific setting, the jury is still out on whether they are a ‘game-changer’ for oncology and can justify current valuations and investor interest.
 

Drug discovery in a multi-omics world

By Mike Furness
Collectively rare diseases affect millions of people worldwide, but the number of people with any one condition is very small. Finding a cure is difficult as the market is not large enough to justify a big investment in drug development.
 

Phenotypic Drug Discovery: striving towards the highest level of biological relevance

By Dr John Comley
Phenotypic drug discovery (PDD) implies screening where the molecular mechanism of action is not assumed and does not require knowledge of the molecular target.
 

Seeing within: Magnetic Resonance Imaging in drug development

By Dr Geoff J.M. Parker
Magnetic Resonance Imaging (MRI) can be used to provide quantitative measurements in the form of imaging biomarkers. These measurements have attractive characteristics: non-invasive, can provide organ and lesion localisation of morphology, physiology and metabolism and can be repeated over time.
 

Therapeutic Drug Repurposing, Repositioning and Rescue Part IV: Financial model and analysis

By David M. Kauppi and Dr Stephen Naylor
There is a growing consensus that Drug Repurposing, Repositioning and Rescue (DRPx) impacts all stakeholders involved in the therapeutic drug sector.
 




Innova Biosciences Introduces Thunder-Link PLUS

18 January 2016: Innova Biosciences , specialist provider of bioconjugation products and services, today announced the launch of Thunder-Link® PLUS, a new and improved version of the original Thunder-Link kit.
 

Enzo launches ultra-sensitive highly specific VEGF ELISA Kit

Enzo Life Sciences continues to expand its ELISA portfolio. A leading manufacturer of high quality ELISAs, Enzo continues to invest in developing immunoassays with the launch of their new VEGF ELISA Kit.
 

Enzo Launches EQ Quencher Dyes for Molecular Biology FRET Applications

Enzo Life Sciences now offers EQ Quencher Dyes – amine-reactive quencher dyes that can be used for fluorescence resonance energy transfer (FRET) applications.
 

ImageXpress Micro Confocal High-Content Imaging System Expands the Boundaries of Research

Molecular Devices launches a new confocal technology at the speed of widefield imaging.
 

Cayman Chemical and the University of Michigan Issued US Patent for SAM-Screener Epigenetic Methylation Test

The United States Patent and Trademark Office has issued a patent to Cayman Chemical and the University of Michigan claiming novel reagents used for screening small-molecule chemical libraries for new drug leads.